These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8656532)

  • 21. An international survey of the diagnosis, management, and treatment of hepatitis C in patients with end-stage renal disease.
    Olson MR; Grewal KS; Bingaman A; Zaki R; Stewart S; Horton J; Araya V; Ortiz J
    Exp Clin Transplant; 2009 Dec; 7(4):203-13. PubMed ID: 20353368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Fluctuation of hepatitis C virus quasispecies with interferon treatment and interferon-resistant variants in hepatitis C virus 1b].
    Sakuma I; Enomoto N; Asahina Y; Kurosaki M; Sato C
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):930-5. PubMed ID: 7563904
    [No Abstract]   [Full Text] [Related]  

  • 23. [HCV-serotype and IFN response].
    Abe K; Miyakawa H; Kako M; Horikoshi K
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):959-64. PubMed ID: 7563910
    [No Abstract]   [Full Text] [Related]  

  • 24. Newly acquired hepatitis C--many hurdles from diagnosis until treatment initiation.
    Wiegand J
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1782-4. PubMed ID: 19120870
    [No Abstract]   [Full Text] [Related]  

  • 25. [HCV-RNA quantity of the serum].
    Sasaki Y; Hige S; Nagasaka A; Matsushima T
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):965-8. PubMed ID: 7563911
    [No Abstract]   [Full Text] [Related]  

  • 26. [Incidence of hepatocellular carcinoma in patients treated with interferon].
    Yokosuka O; Omata M
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):805-9. PubMed ID: 7563880
    [No Abstract]   [Full Text] [Related]  

  • 27. [Liver histology as a predictor of the response to interferon therapy].
    Okuno T; Arai K; Shindo M
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):975-80. PubMed ID: 7563913
    [No Abstract]   [Full Text] [Related]  

  • 28. [Change of HCV-RNA levels in liver tissue and interferon responsiveness in patients with chronic hepatitis C].
    Takeuchi M; Kaneko S; Unoura M; Kobayashi K
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):969-74. PubMed ID: 7563912
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hepatitis C: from pathogenesis to treatment].
    Delarive J; Berger JP
    Schweiz Rundsch Med Prax; 1993 Nov; 82(45):1278-83. PubMed ID: 7505477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiviral agents in the treatment of chronic viral hepatitis.
    Perrillo RP
    Prog Liver Dis; 1992; 10():283-309. PubMed ID: 1284255
    [No Abstract]   [Full Text] [Related]  

  • 31. Interferon therapy in hepatitis C virus (HCV) induced chronic hepatitis: clinical significance of pretreatment with glycyrhizine.
    Fujisawa K
    Trop Gastroenterol; 1991; 12(4):176-9. PubMed ID: 1726032
    [No Abstract]   [Full Text] [Related]  

  • 32. Hepatitis C, interferon, and risk of rejection after liver transplantation.
    Samuel D
    Liver Transpl; 2004 Jul; 10(7):868-71. PubMed ID: 15237370
    [No Abstract]   [Full Text] [Related]  

  • 33. [Interferon therapy for acute hepatitis C: evaluation by HCV antibody, HCV genotypes and serum RNA titer].
    Toyama H; Iwabuchi S
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):521-7. PubMed ID: 7563813
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of type C fulminant and subfulminant hepatitis--featuring antiviral and immunosuppressive treatment].
    Yoshiba M
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):549-56. PubMed ID: 7563822
    [No Abstract]   [Full Text] [Related]  

  • 35. Hepatitis C: a hidden, growing problem.
    Kennedy M
    WMJ; 2000 Aug; 99(5):24-5. PubMed ID: 11043065
    [No Abstract]   [Full Text] [Related]  

  • 36. Hepatitis C in childhood.
    Sibal A; Mishra D; Arora M
    J Indian Med Assoc; 2002 Feb; 100(2):93-8. PubMed ID: 12206357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of chronic hepatitis C: still many problems pending].
    Bruguera M
    Gastroenterol Hepatol; 1997 Jan; 20(1):31-42. PubMed ID: 9072195
    [No Abstract]   [Full Text] [Related]  

  • 38. [Screening and treatment of acute hepatitis C].
    Grangé JD
    Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 1):285-7. PubMed ID: 12700513
    [No Abstract]   [Full Text] [Related]  

  • 39. [Should we treat cirrhosis in hepatitis C carriers with antiviral agents?].
    Brenard R; Closon ML; Fevery J; Hautekeete M
    Rev Med Brux; 1999 Feb; 20(1):A50. PubMed ID: 10091538
    [No Abstract]   [Full Text] [Related]  

  • 40. [Update on hepatitis C: potential transmission by invasive medical examinations; new therapeutic modalities (1)].
    Delwaide J
    Rev Med Liege; 1998 Aug; 53(8):467-9. PubMed ID: 9810206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.